Advanced Practice Provider (NP/PA) - Inpatient Hematology - Rotational

Advanced Practice Provider (NP/PA) - Inpatient Hematology - Rotational

The Advanced Practice Provider (APP) is responsible for providing health care services to patients within the parameters of a standard care or supervisory agreement with an attending physician member of The Ohio State University Wexner Medical Center. Collaborates with a physician(s) and other clinicians in providing a full scope of patient care. The focus is on preventive health or the management of acute and/or stable chronic conditions. Performs medical services that have been specifically authorized and directed by the credentialing body and the certifying organization through which they hold licensure.

The APP provides health care services to patients working in collaboration with a licensed physician member of the medical staff. Healthcare services provided include care during acute and chronic phases of illness, education, and counseling of individuals and families, health promotion and prevention, and referral to other healthcare providers and community resources when appropriate.

Minimum Qualifications:

• Current certificate of authority to practice as an APRN in the State of Ohio
• Graduate of a Nurse Practitioner program that qualifies the graduate to sit for the certification examination of a national certifying organization recognized by the Ohio Board of Nursing
• Master of Science Degree in Nursing
• 0 years of relevant experience required.
• 0-2 years of BMT/Cell Therapy experience preferred.

OR

• Masters Prepared; Graduate of a PA-C program that qualifies the graduate to sit for the certification examination recognized by the National Certification Commission for Physician Assistants (NCCPA).
• Eligibility for State of Ohio licensure as a PA-C
• 0 years of relevant experience required.
• 0-2 years of BMT/Cell Therapy experience preferred.

Brand new service line to take care of patients with cutting edge treatment methods including Chimeric Antigen Receptor Therapy (CAR-T), Tumor Infiltrating Lymphocyte (TIL), gene therapy for both hematology and non hematology malignancies

James Cancer Hospital (0375)

Regular

40

Rotating Shift